Trispecific Antibody – Talk Bio

Actionable Insights Powered by AI

AbbVie and Simcere Zaiming Collaborate on Novel Trispecific Antibody for Multiple Myeloma Treatment

5 months ago talkbio0Tagged AbbVie, bis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)amine, CD3 Antigens, GPRC5D, GPRC5D gene, Multiple Myeloma, Simcere, T-Lymphocyte, Trispecific Antibody, Zaiming

AbbVie, Simcere Zaiming, multiple myeloma, trispecific antibody, SIM0500, T-cell engager, GPRC5D, BCMA, CD3

Merck & Co. Revives Ophthalmology Efforts with $3 Billion EyeBio Acquisition ###

1 year ago talkbio0Tagged Acquisition (action), Biotechnology, EyeBio, Merck & Co., Ophthalmology specialty, Trispecific Antibody

Merck & Co., EyeBio, Ophthalmology, Trispecific antibody, Restoret, Acquisition, Biotechnology, Pharmaceuticals